Guildford, United Kingdom

Vanessa Cofre

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Incyte Corporation. Active years: 2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vanessa Cofre: Innovator in Topical Formulations for Skin Diseases

Introduction

Vanessa Cofre is a prominent inventor based in Guildford, GB. She has made significant contributions to the field of dermatology through her innovative work on topical formulations. Her research focuses on the treatment of various skin diseases, showcasing her dedication to improving patient care.

Latest Patents

Vanessa Cofre holds 1 patent for her invention titled "Topical formulations of ruxolitinib with an organic amine pH adjusting agent for treatment of skin diseases." This patent relates to topical formulations and methods for treating skin diseases using ruxolitinib, a JAK 1/2 inhibitor, combined with an organic amine pH adjusting agent. The formulations target a range of skin conditions, including psoriasis, atopic dermatitis, and vitiligo, among others.

Career Highlights

Cofre's career is marked by her role at Incyte Corporation, where she has been instrumental in advancing research and development in dermatological treatments. Her expertise in formulating effective topical solutions has positioned her as a key player in the pharmaceutical industry.

Collaborations

Throughout her career, Vanessa has collaborated with notable colleagues, including Marc Brown and Charles Evans. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Vanessa Cofre's contributions to the field of dermatology through her innovative patent demonstrate her commitment to addressing complex skin diseases. Her work continues to inspire advancements in topical treatments, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…